Genetron Holdings Stock Book Value Per Share
Genetron Holdings fundamentals help investors to digest information that contributes to Genetron Holdings' financial success or failures. It also enables traders to predict the movement of Genetron Stock. The fundamental analysis module provides a way to measure Genetron Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genetron Holdings stock.
Genetron |
Genetron Holdings Company Book Value Per Share Analysis
Genetron Holdings' Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Genetron Holdings Book Value Per Share | 17.90 X |
Most of Genetron Holdings' fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genetron Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Genetron Holdings is about 17.896 times. This is 1152.71% lower than that of the Biotechnology sector and 117.97% lower than that of the Health Care industry. The book value per share for all United States stocks is 99.07% higher than that of the company.
Genetron Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genetron Holdings' direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genetron Holdings could also be used in its relative valuation, which is a method of valuing Genetron Holdings by comparing valuation metrics of similar companies.Genetron Holdings is currently under evaluation in book value per share category among its peers.
Genetron Fundamentals
| Return On Equity | -0.92 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.24) % | |||
| Operating Margin | (0.87) % | |||
| Current Valuation | 102.87 M | |||
| Shares Outstanding | 31.62 M | |||
| Shares Owned By Insiders | 6.82 % | |||
| Shares Owned By Institutions | 12.51 % | |||
| Number Of Shares Shorted | 20.78 K | |||
| Price To Book | 1.68 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 650.71 M | |||
| Gross Profit | 337.97 M | |||
| EBITDA | (546.24 M) | |||
| Net Income | (810.63 M) | |||
| Cash And Equivalents | 472.68 M | |||
| Cash Per Share | 5.10 X | |||
| Total Debt | 158.57 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 2.83 X | |||
| Book Value Per Share | 17.90 X | |||
| Cash Flow From Operations | (460.2 M) | |||
| Short Ratio | 0.29 X | |||
| Earnings Per Share | (3.62) X | |||
| Target Price | 1.34 | |||
| Number Of Employees | 993 | |||
| Beta | 0.5 | |||
| Market Capitalization | 127.29 M | |||
| Total Asset | 975.33 M | |||
| Retained Earnings | (6.25 B) | |||
| Working Capital | 319.08 M | |||
| Z Score | -9.27 | |||
| Net Asset | 975.33 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Genetron Stock
If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |